BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3877520)

  • 21. Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study.
    Bergfelt L
    Acta Derm Venereol Suppl (Stockh); 1993; 180():1-37. PubMed ID: 7901956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the inflammatory infiltrate in lupus erythematosus lesions using monoclonal antibodies.
    Synkowski DR; Provost TT
    J Rheumatol; 1983 Dec; 10(6):920-4. PubMed ID: 6607342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cell subsets and Langerhans cells in skin tumours.
    Fernandez-Bussy R; Cambazard F; Mauduit G; Schmitt D; Thivolet J
    Eur J Cancer Clin Oncol; 1983 Jul; 19(7):907-13. PubMed ID: 6603978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of a double-label immunoperoxidase monoclonal antibody technique in the investigation of patients with mycosis fungoides.
    Mackie RM; Turbitt ML
    Br J Dermatol; 1982 Apr; 106(4):379-84. PubMed ID: 6462162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T cell subsets and macrophages in lichen planus. In situ identification using monoclonal antibodies and histochemical techniques.
    Buechner SA
    Dermatologica; 1984; 169(6):325-9. PubMed ID: 6241156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The immunobiology of skin cancer.
    Dellon AL; Potvin C; Chretien PB; Rogentine CN
    Plast Reconstr Surg; 1975 Mar; 55(3):341-354. PubMed ID: 1078893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-mediated immunity of patients who have had basal cell carcinomas.
    Czarnecki D; Mar A; Kulinskaya E
    Acta Derm Venereol; 1996 Jan; 76(1):28-30. PubMed ID: 8721486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of retraction spaces in basal cell carcinoma using an antibody to type IV collagen.
    McArdle JP; Roff BT; Muller HK
    Histopathology; 1984 May; 8(3):447-55. PubMed ID: 6376324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T lymphocytes with Fc-IgG receptors in skin cancers.
    Vena GA; Angelini G; D'Ovidio R; Lospalluti M; Meneghini CL
    Acta Derm Venereol; 1981; 61(6):555-8. PubMed ID: 6177170
    [No Abstract]   [Full Text] [Related]  

  • 30. Characterization of benign cutaneous lymphocytic infiltrates by monoclonal antibodies.
    Ralfkiaer E; Lange Wantzin G; Mason DY; Stein H; Thomsen K
    Br J Dermatol; 1984 Dec; 111(6):635-45. PubMed ID: 6391533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lymphocyte subpopulations in multiple myeloma. Shift in the helper/suppressor cell relation].
    Ludwig H; Fritz E
    Acta Med Austriaca; 1982; 9(5-6):215-20. PubMed ID: 6219532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased anchoring-fibril antigens (AF1 and AF2) in basal-cell carcinoma.
    Lane AT; Goldsmith LA; McCoon PE; Muhlbauer JE
    Arch Dermatol Res; 1985; 277(6):499-501. PubMed ID: 4051560
    [No Abstract]   [Full Text] [Related]  

  • 33. Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies.
    Moch C; Moysan A; Lubin R; de la Salmonière P; Soufir N; Galisson F; Vilmer C; Venutolo E; Le Pelletier F; Janin A; Basset-Séguin N
    Br J Cancer; 2001 Dec; 85(12):1883-6. PubMed ID: 11747330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cell population in the cutaneous infiltrate of mycosis fungoides: in situ using monoclonal antisera.
    Holden CA; Morgan EW; MacDonald DM
    Br J Dermatol; 1982 Apr; 106(4):385-92. PubMed ID: 6462163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impairment of thymus-derived lymphoid cell function in patients with basal cell carcinoma.
    Dellon AL; Elfenbein GJ; Orlando JC
    J Surg Oncol; 1984 Feb; 25(2):92-7. PubMed ID: 6607384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ganglioside, adhesion molecule, and HLA antigen expression in basal cell carcinoma lesions.
    Kageshita T; Ono T; Hirai S; Yoshii A; Kimura T; Nakakuma H; Horikawa K; Takatsuki K; Ferrone S
    Cancer Res; 1992 Jun; 52(11):3201-7. PubMed ID: 1350511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactivity of T lymphotropic retrovirus antibody (12/1-2) in man: comparison of epidermis with other epithelial cells.
    Ralfkiaer E; Pulford KA; Gatter KC; Wantzin GL; Mason DY
    J Clin Pathol; 1986 May; 39(5):547-52. PubMed ID: 2424935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of human leukocyte antigen molecules in skin tumors and some cutaneous appendages: evidence using monoclonal antibodies.
    Holden CA; Sanderson AR; MacDonald DM
    J Am Acad Dermatol; 1983 Dec; 9(6):867-71. PubMed ID: 6196384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal T lymphocyte subpopulations in patients with B cell chronic lymphocytic leukemia: an analysis by monoclonal antibodies.
    Platsoucas CD; Galinski M; Kempin S; Reich L; Clarkson B; Good RA
    J Immunol; 1982 Nov; 129(5):2305-12. PubMed ID: 6214590
    [No Abstract]   [Full Text] [Related]  

  • 40. Papular polymorphic light eruption: an immunoperoxidase study using monoclonal antibodies.
    Muhlbauer JE; Bhan AK; Harrist TJ; Bernhard JD; Mihm MC
    Br J Dermatol; 1983 Feb; 108(2):153-62. PubMed ID: 6337616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.